Plus   Neg

Eli Lilly Announces Several Leadership Changes - Quick Facts

Eli Lilly and Co. (LLY) announced Wednesday several leadership changes in the company's corporate business development, oncology R&D, and managed healthcare services organizations.

The company said Darren Carroll, senior vice president of corporate business development, will retire at the end of August after 22 years of service with the company.

Carroll will be succeeded by Heather Wasserman with responsibility for business development transactions, emerging technologies and innovation, and venture capital.

Meanwhile, Phil Johnson, senior vice president and treasurer, will assume additional duties overseeing merger & acquisition activity.

Levi Garraway has resigned from his position as senior vice president of oncology research and early phase development in order to pursue other opportunities. Garraway will be succeeded by Josh Bilenker, CEO of Loxo Oncology, on an interim basis.

Additionally, Frank Cunningham has been promoted to senior vice president of managed healthcare services.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
WeWork's parent company, We Company, said it has filed a lawsuit against Japanese conglomerate SoftBank Group Corp. for failing to consummate a $3 billion tender offer for the company's shares. After WeWork's failed attempt at an initial public offering last year, SoftBank acquired a majority stake in the office sharing company in a bailout, severing most ties with WeWork co-founder Adam Neumann. Walgreens is expanding drive-thru testing for the coronavirus to fifteen new locations in seven states across the U.S. later this week. They include Arizona, Florida, Illinois, Kentucky, Louisiana, Tennessee and Texas. The drive-thru locations are part of Walgreens' collaboration with the administration, federal health agencies, and state and local authorities to expand access to COVID-19 testing. iPhone assembler Foxconn, otherwise known as Hon Hai Precision Industry Co. Ltd., is reportedly set to start manufacturing ventilators in the United States in partnership with medical device firm Medtronic plc., as the U.S. braces for the cornavirus (COVID-19) infection peak. Taiwan-based Foxconn will start manufacturing ventilators at its Wisconsin factory within the next four to six weeks.
Follow RTT